/trajan%20logo.png?width=410&height=94&name=trajan%20logo.png "trajan logo")
Synexa Life Sciences
Improving the quality of human health through innovative biomarker and bioanalytical solutions
For over 20 years, Synexa Life Sciences has supported large and emerging biopharma customers across the globe to achieve their clinical milestones through the delivery of cutting-edge biomarker and bioanalytical services. Synexa specializes in the development, validation, and delivery of a wide range of complex and custom-designed assays across five laboratory locations.
Synexa Life Sciences’ guiding principles are reflected in a collaborative approach to providing customized, flexible solutions to meet our customers' specific needs. We pride ourselves on our scientific knowledge and our ability to partner with our customers to contribute to the advancement of scientific development and, ultimately, better management and treatment of human health.
Synexa offers a comprehensive range of analytical and advisory services comprising the identification, development, validation, analysis and interpretation of biomarker and bioanalytical readouts in translational and clinical research. Our expertise lies in four key areas including Vaccines, Biosimilars, Immunology and Oncology, with our team having extensive experience within each.
Our primary analytical expertise centers on large molecules, cellular and genetic bioanalysis, employing analytical platforms including:
• MSD
• ELISA
• Radioimmunoassay
• DELFIA
• AlphaLISA
• Gyrolab
• Luminescence and fluorescence
• Flow cytometry (up to 30 colours)
• ELISpot
• Digital PCR
• Targeted sequencing
• RT-PCR
• NanoString
We use innovative approaches and validated platforms such as our proprietary ProtoTrials® solution, to answer client-specific questions related to biomarkers at each level of the biological continuum including biomarker discovery, validation, or data interpretation.
Synexa Life Sciences is GLP, GCP, and ISO accredited.
Synexa is led by a growing team of industry experts and highly experienced scientists based across five laboratory locations including Berlin, London, Cape Town, Turku (Finland) and Rockville, Maryland (USA). Priding ourselves as a leading player at the forefront of our industry we have recently acquired Syrinx Bioanalytical group to enhance our offering and provide our customers with a broader range of services, deeper scientific expertise, and a wider set of analytical platforms across an expanded geographical footprint.